Skip to content
Articles

Positive results from first-in-human trial of nanoformed piroxicam

Overcoming Drug Development Challenges with Nanotechnology: Piroxicam, a commercially available non-steroidal anti-inflammatory drug, was nanoformed as a model compound to demonstrate the potential benefits of our CESS(R) nanoforming technology for improving solubility, dissolution and in vivo absorption.